Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 9.0 Good

Longevica Advances Longevity Research with Advisory Board and Pipeline

This matters as it leverages the world's largest in vivo longevity study to unlock health and lifespan improvements, potentially benefiting human longevity.

This matters as it leverages the world’s largest in vivo longevity study to unlock health and lifespan improvements, potentially benefiting human longevity.

Auto-scored: No AI risk factors present; mitigation reflects a substantive health development based on verified study.